Denali Therapeutics

Denali Therapeutics is dedicated to defeating neurodegenerative diseases by breaking through historical barriers in scientific research and clinical development in order to deliver safe and effective medicines to patients and families.



Series B




Org chart

Alex Schuth
Chief Operating & Financial Officer
Carole Ho
Chief Medical Officer
Dana Andersen
Chief Technical & Manufacturing Officer
Cindy Dunkle
Chief People Officer
Joe Lewcock
Chief Scientific Officer
Katie Peng
Chief Commercial Officer
Chris Walsh
General Counsel
Cynthia Wong
SVP, Portfolio & Program Management
Michelle Polowski
SVP, Development Operations
Fabian Model
VP, Biometrics
Wei Dong
VP, Drug Safety
Kirk Henne
VP, Development Sciences
Michael Ostland
VP, Development - Europe
Amanda Sani
Senior Manager, Corporate Development
Two candidates
The Org
helps you hire
great candidates
It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.